Clinical trial
Aerobic Versus Anaerobic Exercise on Immune Functions and Disease Severity in Patients With COVID-19: A Randomized Control Trial
NCT05000008 is registered in ClinicalTrials.gov with Istanbul Gelisim University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aerobic Versus Anaerobic Exercise on Immune Functions and Disease Severity in Patients With COVID-19: A Randomized Control Trial
- Lead sponsor
- Istanbul Gelisim University
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 1, 2021
- Completion date
- October 1, 2021
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, immune response